Essential psychiatric medicines: wrong selection, high consumption and social problems.

ABSTRACT:

Background

The World Health Organization Essential Medicines List (WHO-LIST) and national essential medicines lists differ because many countries face significant challenges, such as product availability, cost, product quality and epidemiological disease profiles. In Brazil, governments pay for drugs that are included on the federal, state and municipal government (REMUME) lists. The extent to which municipal lists differ from state and national lists and from the WHO-LIST is unclear. We investigate the use of the WHO-LISTas a tool with which to evaluate the selection process for the essential psychiatric medicines in the public system coverage list of Brazilian communities (cities) and the use of the target drugs.

Methods

Municipal health secretaries were interviewed regard

SUBMITTER: Fulone I 

PROVIDER: S-EPMC4719662 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature